IHR Emergency Committee regarding the multi-country outbreak of monkeypox – World Health Organization

Share Article

The Director-General of WHO is convening an Emergency Committee under Article 48 of the International Health Regulations in relation to the current outbreak of monkeypox virus. The meeting will take place on 23 June 2022 and is open only to members and advisors of the Emergency Committee. 

The objectives of this meeting are to provide views to the Director-General of WHO on whether the event constitutes a public health emergency of international concern and also on proposed potential Temporary Recommendations.
List of participants
Chair
Dr Jean-Marie Okwo-Bele – Public Health Consultant, national of the Democratic Republic of the Congo
Former Director of the Vaccines and Immunization Department, WHO headquarters, Geneva, Switzerland (Retired)
Co-chair
Dr Nicola Low – Associate Professor of Epidemiology and Public Health Medicine, Institute of Social and Preventive Medicine, University of Bern, Switzerland
Other members 

Dr Daniel Bausch – Senior Director, Emerging Threats and Global Health Security, FIND, The Global Alliance for Diagnostics, Switzerland
Dr Clarissa Damaso – Associate Professor, Head, Laboratory of Molecular Biology of Viruses, Carlos Chagas Filho Biophysics Institute, Federal University of Rio de Janeiro, Brazil
Dr Inger Damon (Rapporteur) – Director, Division of High Consequence Pathogens and Pathology, Centers for Disease Control and Prevention, United States of America 
Dr Jake Dunning – Senior Researcher, Centre for Tropical Medicine and Global Health, Nuffield Department of Clinical Medicine, University of Oxford, United Kingdom
Dr Ousmane Faye – Head, Virology Unit, Institut Pasteur de Dakar, Senegal
Dr Rinat Maksyutov – Director General, Federal Budgetary Research Institution – State Research Center of Virology and Biotechnology VECTOR, Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing, Russian Federation
Dr Othoman Mellouk – Lead, Access to Diagnostics and Medicines, International Treatment Preparedness Coalition, Morocco
Dr Dimie Ogoina – Professor of Medicine and Infectious Diseases, Niger Delta University and Head of Infectious Diseases Unit, Niger Delta University Teaching Hospital, Bayelsa, Nigeria
Dr Nittaya Phanuphak – Executive Director, Institute of HIV Research and Innovation, Bangkok, Thailand
Dr Anne Rimoin – Professor of Epidemiology and Gordon-Levin Endowed Chair in Infectious Diseases and Public Health, Fielding School of Public Health, University of California, Los Angeles, United States of America
Dr Tomoya Saito – Director, Center for Emergency Preparedness and Response, National Institute of Infectious Diseases, Japan
Dr Kathrin Summermatter – Head of Biosafety Center and Managing Director of the BSL3, Institute for Infectious Diseases, University of Berne, Switzerland
Dr Daniel Tarantola – Adjunct Research Professor, Institute on Inequalities in Global Health, Keck School of Medicine, University of Southern California, United States of America and Former Director of the Vaccines and Immunization Department, WHO headquarters, Geneva, Switzerland (Retired)
Dr Zunyou Wu Chief Epidemiologist, Chinese Center for Disease Control and Prevention, Director, Division of HIV Prevention, NCAIDS/China CDC, China and Adjunct Professor of Epidemiology, University of California, Los Angeles, United States
Advisors
Dr Steve Ahuka – Chief, Department of Virology, National Institute of Biomedical Research, Democratic Republic of the Congo
Dr Demetre Daskalakis – Director- Division of HIV/AIDS Prevention, Centres of Disease Control and Prevention, United States of America
Dr Cleiton Euzebio De Lima – Senior Adviser for Communities and Key Populations, UNAIDS headquarters, Geneva, Switzerland
Dr Gregg Gonsalves – Associate Professor of Epidemiology, Yale Institute for Global, Health, Yale School of Public Health, Yale University, United States of America
Dr David Heymann – Professor of Infectious Disease Epidemiology, London School of Hygiene and Tropical Medicine, United Kingdom; Head, Centre on Global Health Security, Chatham House, London, United Kingdom; and Former Assistant Director-General for Health Security, WHO headquarters, Geneva, Switzerland (Retired)
Dr Wanda Markotter – Director, Centre for Viral Zoonoses, Department of Medical Virology, Faculty of Health Sciences, University of Pretoria, South Africa
Dr Gianfranco Spiteri – Group Lead, Epidemic Intelligence Group, European Centre for Disease Prevention and Control, Sweden
Dr Theresa Tam – Chief Public Health Officer, Public Health Agency of Canada, Canada
 
Subscribe to our newsletters →
Related
Monkeypox
International Health Regulations 

source

You might also like

Surviving 2nd wave of corona
COVID-19

Surviving The 2nd Wave of Corona

‘This too shall pass away’ this famous Persian adage seems to be defeating us again and again in the case of COVID-19. Despite every effort

@voguewellness